Stockreport

Inhibrx Biosciences GAAP EPS of -$2.28 [Seeking Alpha]

Inhibrx, Inc.  (INBX) 
PDF More on Inhibrx Biosciences Inhibrx Biosciences: Cruising Toward FDA Approval, But Getting Ahead Of Itself Inhibrx: Positive Ozekibart Data For Bone Cancer Leads To [Read more]